GALMED PHARMACEUTICALS LTD. Shareholders' Equity
GALMED PHARMACEUTICALS LTD. (GLMD) had Shareholders' Equity of $12.74 million as of 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-02
- 2026-06-30: Stockholders' Equity Attributable to Parent $12.74M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $13.95M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $15.78M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $19.11M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $12.74M 6-K · filed 2026-09-02 |
| 2026-03-31 | $13.95M 6-K · filed 2026-09-02 |
| 2025-12-31 | $15.78M 6-K · filed 2026-09-02 |
| 2025-09-30 | $19.11M 6-K · filed 2025-11-26 |
| 2025-06-30 | $20.52M 6-K · filed 2026-09-02 |
| 2025-03-31 | $16.88M 6-K · filed 2026-09-02 |
| 2024-12-31 | $16.33M 6-K · filed 2026-09-02 |
| 2024-09-30 | $18.44M 6-K · filed 2025-11-26 |
| 2024-06-30 | $11.79M 6-K · filed 2025-11-26 |
| 2024-03-31 | $12.76M 6-K · filed 2025-08-28 |
| 2023-12-31 | $13.88M 20-F · filed 2026-03-31 |
| 2023-06-30 | $10.55M 6-K · filed 2024-08-28 |
| 2023-03-31 | $11.99M 6-K · filed 2024-08-28 |
| 2022-12-31 | $13.42M 20-F · filed 2026-03-31 |
| 2022-06-30 | $20.71M 6-K · filed 2023-08-09 |
| 2022-03-31 | $24.37M 6-K · filed 2023-08-09 |
| 2021-12-31 | $30.50M 20-F · filed 2025-04-02 |
| 2021-06-30 | $45.00M 6-K · filed 2022-08-04 |
| 2021-03-31 | $52.96M 6-K · filed 2022-08-04 |
| 2020-12-31 | $44.15M 20-F · filed 2024-04-04 |
| 2020-06-30 | $59.88M 6-K · filed 2021-08-05 |
| 2020-03-31 | $64.10M 6-K · filed 2021-08-05 |
| 2019-12-31 | $69.85M 20-F · filed 2023-03-29 |
| 2019-06-30 | $81.39M 6-K · filed 2020-08-06 |
| 2019-03-31 | $84.93M 6-K · filed 2020-08-06 |
| 2018-12-31 | $87.89M 20-F · filed 2021-03-18 |
| 2018-06-30 | $91.04M 6-K · filed 2019-08-05 |
| 2018-03-31 | $13.60M 6-K · filed 2019-08-05 |
| 2017-12-31 | $15.79M 20-F · filed 2020-03-12 |
| 2017-06-30 | $6.24M 6-K · filed 2017-07-31 |
| 2016-12-31 | $11.07M 20-F · filed 2019-03-13 |
| 2016-06-30 | $14.43M 6-K · filed 2017-06-23 |
| 2015-12-31 | $21.55M 20-F · filed 2018-03-13 |
| 2014-12-31 | $31.41M 20-F · filed 2017-03-23 |
| 2013-12-31 | -$1.95M 20-F · filed 2016-03-22 |
| 2012-12-31 | -$1.98M 20-F · filed 2015-03-31 |
| 2011-12-31 | -$2.71M 20-F · filed 2015-03-31 |